![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HPTN 069 / ACTG A5305 Phase II Study of Maraviroc (MVC)-Containing Regimens for HIV PrEP in Men Who Have Sex With Men (MSM)
|
|
|
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Roy M. Gulick, MD, MPH
Harriman Professor of Medicine
Weill Medical College of Cornell University
for the HPTN 069/ACTG A5305 Team
WEBCAST link: http://www.croiwebcasts.org/console/player/29578?mediaType=audio&
![CROI1](../images/022616/022616-3/CROI1.gif)
![CROI2](../images/022616/022616-3/CROI2.gif)
![CROI3](../images/022616/022616-3/CROI3.gif)
![CROI4](../images/022616/022616-3/CROI4.gif)
![CROI5](../images/022616/022616-3/CROI5.gif)
![CROI6](../images/022616/022616-3/CROI6.gif)
![CROI7](../images/022616/022616-3/CROI7.gif)
![CROI8](../images/022616/022616-3/CROI8.gif)
![CROI9](../images/022616/022616-3/CROI9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|